The changing process of drug discovery and design
14 Jul 2016
The changing process of drug discovery and design
Glioblastoma heterogeneity in circulating tumour DNA
Obesity promotes pancreatic cancer progression and resistance
Connections in cancer-host immune signalling
Targeting and imaging invasion and metastasis
ERß expression predicts breast cancer risk in hyperplasia
Advances in early detection
Polygenic risk and the targeted prevention of cancer
Regulation of T cells in tissues and tumours
Physical pressure of tumour on healthy cells induces oncogenes
ß1 integrins and DNA repair for radiosensitization of head and neck cancer
Understanding mutational processes in human cancer